BioStacks

Amino Acid

Tyrosine

Evidence

Limited

Reviewed May 2026

Evidence: 2 of 5 (Limited)

7 studies cited

What the evidence says

L-Tyrosine is a non-essential amino acid and direct precursor to dopamine, norepinephrine, and epinephrine. Also a building block for thyroid hormones (T3/T4).

Multiple trials show it preserves cognitive function under acute stress like cold or sleep deprivation

Top Tyrosine supplements for…

Supports

BrainModerate
Stress & MoodLimited
EnergyPreliminary

Top Tyrosine supplements

2/5

Limited

7

RCTs reviewed

1

Null result

Works in a narrow, well-defined situation: as a catecholamine (dopamine/norepinephrine) precursor, tyrosine preserves cognitive performance under acute stressors that deplete those neurotransmitters — cold, sleep deprivation, multitasking, and military-style load. It is NOT a general mood booster, daily focus aid, or depression treatment. The effect is protective under load, not enhancing at baseline.

Tyrosine helps when you are under acute stress that drains catecholamines — not as a daily pick-me-up in a rested, healthy person. It also interacts with MAOIs, thyroid medication, and levodopa.

Research dossier

Clinical research on Tyrosine

7 trials reviewed across 3 indications.

Strongest evidence

Cognitive performance under acute stress

Moderate

Mechanism

Tyrosine is the dietary precursor for dopamine and norepinephrine. Acute stressors — cold, sleep loss, high cognitive load, threat — accelerate catecholamine turnover faster than the brain can resynthesize them. Supplying extra precursor lets synthesis keep pace, protecting the dopamine- and norepinephrine-dependent circuits that run working memory and vigilance. With no stressor, turnover isn't outpacing supply, so extra precursor does nothing.

This is tyrosine's real and best-supported use. Across sleep deprivation (Neri 1995), cold (Mahoney 2007), multitasking (Thomas 1999), an N-back working-memory task (Colzato 2013), and military training (Deijen 1999), tyrosine preserved cognitive performance under load. Crucially, the benefit appears only in the demanding condition — the easy condition shows nothing.

Demonstrated only under acute stressors or high cognitive load. There is no evidence it sharpens focus or memory in rested, unstressed people at baseline.

Trials cited

  • Tyrosine during sleep deprivation and sustained work

    positive · RCT

    Neri et al., 1995, Aviation, Space, and Environmental Medicinen=20

    A foundational sleep-deprivation study. A single 150 mg/kg split dose of tyrosine significantly reduced the usual performance decline on a psychomotor task and cut lapse probability on a demanding vigilance task in adults kept awake for over 24 hours. The benefit lasted roughly 3 hours.

    Benefit was transient (~3 h) and confined to a stressed, sleep-deprived state. This is a countermeasure for acute decrement, not a daily nootropic — and it does not enhance performance in rested people.

  • Tyrosine and working memory during cold exposure

    positive · RCT

    Mahoney et al., 2007, Physiology & Behaviorn=19

    Cold exposure degraded working memory; tyrosine reversed part of that decrement. With tyrosine, correct responses on a Match-to-Sample memory task increased and study time shortened (both p<0.05). A clean demonstration of the core mechanism: tyrosine protects cognition specifically when an acute environmental stressor depletes catecholamines.

    Acute, lab cold-stress paradigm with a small sample (n=19). It shows protection under a specific stressor, not a generalizable cognitive boost.

  • Tyrosine and working memory in a multitasking environment

    positive · RCT

    Thomas et al., 1999, Pharmacology Biochemistry and Behaviorn=20

    Tyrosine improved working-memory accuracy and reduced list-retrieval errors specifically during the demanding multiple-task battery — but produced no change on the arithmetic, visual, or auditory subtasks, and no effect at all on the simple (low-load) battery. The benefit appears only when competing task demands degrade performance.

    Effect was selective to the high-load condition and to one task type. No benefit emerged at low cognitive load, reinforcing that tyrosine is load-dependent, not a baseline enhancer.

  • Tyrosine repletes working-memory updating (N-back)

    positive · RCT

    Colzato et al., 2013, Frontiers in Behavioral Neurosciencen=22

    Tyrosine improved accuracy on the demanding 2-back condition (91.4% vs 86.5% placebo) and reduced false alarms — but did nothing for the easier 1-back condition. Direct evidence that tyrosine's benefit scales with cognitive demand: it helps when the dopaminergic working-memory system is taxed, not when it isn't.

    Small, single-session study in young women only. The flat 1-back result is the important part: at low load there is no benefit to extract.

  • Tyrosine in cadets during a combat training course

    positive · RCT

    Deijen et al., 1999, Brain Research Bulletinn=21

    Under sustained real-world stress, cadets given a tyrosine-rich drink performed better on memory and tracking tasks than the carbohydrate-control group, and showed lower systolic blood pressure. One of the few multi-day, field-condition tyrosine trials — and it again found cognitive benefit under heavy load with no effect on mood.

    Small (n=21), two-group field study with a carbohydrate (not inert) comparator. Generalizes to high-stress operational settings, not to ordinary daily life. No mood benefit was seen.

Stress resilience & mood

Mechanism

By keeping catecholamine synthesis ahead of stress-driven depletion, tyrosine may blunt the cognitive and cardiovascular cost of acute stress (the Deijen trials saw small blood-pressure reductions). This is a buffering effect on the stress response — not a serotonergic or mood-elevating action.

Tyrosine helps the brain cope with an acute stressor, but it is not a mood drug. The Deijen studies found cognitive and modest blood-pressure benefits under stress with explicitly no effect on mood, and the Gelenberg 1990 RCT found no antidepressant effect in major depression despite confirming the precursor reached its target. 'Tyrosine for mood' overstates the evidence.

Buffers acute stress load; does not treat depression and does not reliably lift mood in healthy people. Not a substitute for mental-health care.

  • Tyrosine and cognition under noise stress

    positive · RCT

    Deijen & Orlebeke, 1994, Brain Research Bulletinn=16

    Tyrosine improved performance on two stress-sensitive cognitive tasks tested 1 hour after dosing, and transiently lowered diastolic blood pressure. Notably, it produced no effect on mood, heart rate, or systolic BP — an early signal that tyrosine acts on stress-loaded cognition, not on mood or general arousal.

    Small (n=16), single-dose lab study. The cognitive benefit was confined to the most stress-sensitive tasks; tasks not sensitive to stress showed no change.

  • Tyrosine in cadets during a combat training course

    positive · RCT

    Deijen et al., 1999, Brain Research Bulletinn=21

    Under sustained real-world stress, cadets given a tyrosine-rich drink performed better on memory and tracking tasks than the carbohydrate-control group, and showed lower systolic blood pressure. One of the few multi-day, field-condition tyrosine trials — and it again found cognitive benefit under heavy load with no effect on mood.

    Small (n=21), two-group field study with a carbohydrate (not inert) comparator. Generalizes to high-stress operational settings, not to ordinary daily life. No mood benefit was seen.

  • Tyrosine for major depression (null)

    Null · RCT

    Gelenberg et al., 1990, Journal of Affective Disordersn=65

    A proper double-blind, three-arm RCT. Tyrosine raised the catecholamine metabolite MHPG (confirming it reached the relevant pathway) but produced NO antidepressant effect versus placebo. The mechanism engaged; the clinical outcome did not. This is the key counterweight to the idea that 'more dopamine precursor = better mood.'

    Definitive on the point it tests: tyrosine is not an antidepressant. Raising precursor availability does not equal raising mood in non-stress-depleted brains.

Daily energy & focus

Mechanism

Marketed as a dopaminergic 'focus and energy' aid, but the dopamine-precursor mechanism only becomes rate-limiting under stress-driven depletion. At baseline, tyrosine availability is not what limits catecholamine synthesis.

Essentially unsupported as a daily energy or focus supplement. Every positive tyrosine trial required an acute stressor or a high-load task to show an effect; the low-load and rested conditions consistently show nothing. Taking tyrosine as a routine pick-me-up in a rested, healthy state has no trial support.

No evidence of benefit for daily energy or focus in rested, unstressed adults.

2 forms of Tyrosine compared
  • L-tyrosine (free form)

    Well absorbed; reliably raises plasma tyrosine

    Best forCognitive performance under acute stress (cold, sleep loss, multitasking, operational stress)

    The form used in essentially every positive clinical trial. Acute-stress protocols use 100–150 mg/kg as a single dose (~7–13 g for a 70 kg adult, well above the typical 500–2000 mg supplement dose); the multi-day cadet study used 2 g/day. This is the form to use if you want the evidence-backed effect.

  • N-acetyl-L-tyrosine (NALT)

    Highly water-soluble but converts to tyrosine poorly; a large fraction is excreted unchanged in urine

    Best forMarketed as a 'better-absorbed' tyrosine — a claim the pharmacology does not support

    Supplement marketing promotes NALT as a superior, more bioavailable tyrosine because it dissolves better. In practice the acetyl group is cleaved inefficiently and much of an oral NALT dose is excreted in urine before becoming usable tyrosine, so it raises plasma tyrosine LESS reliably than plain L-tyrosine. The clinical trials all used free L-tyrosine, not NALT. Pay for the form that was actually studied.

Are you deficient? Symptoms, risk groups, lab tests

Tyrosine is a non-essential amino acid the body makes from phenylalanine, so dietary 'tyrosine deficiency' is not a normal concern. It is supplemented for an acute pharmacological effect (catecholamine-precursor support under stress), not to correct a shortfall. The exception is phenylketonuria (PKU), where impaired phenylalanine metabolism can make tyrosine conditionally essential and supplementation is medically managed.

Who is at risk

  • People with phenylketonuria (PKU)

    In PKU, phenylalanine cannot be converted to tyrosine, so tyrosine becomes conditionally essential and intake is managed clinically. This is the one genuine 'need' scenario — and it is handled by a metabolic specialist, not a generic supplement.

Side effects and drug interactions

Side effects

  • Generally well tolerated

    Common

    At typical and even high single research doses (100–150 mg/kg), tyrosine is well tolerated in healthy adults. The most common complaints are mild and short-lived.

  • Mild GI upset, nausea, or headache

    Uncommon

    Occasional stomach upset, nausea, or headache, more likely at the large single doses used in acute-stress research than at typical supplement doses.

  • Overstimulation, jitteriness, or insomnia

    Uncommon

    As a catecholamine precursor, tyrosine can feel activating in some people, particularly if taken late in the day or combined with stimulants.

  • Hypertensive reaction with MAOIs

    Severe

    Tyrosine is metabolically adjacent to tyramine, which can trigger a dangerous blood-pressure spike in people taking MAO inhibitors. This is a serious interaction, not a routine side effect.

Drug interactions

  • Other

    MAO inhibitors (phenelzine, tranylcypromine, selegiline, isocarboxazid)

    MAOIs block breakdown of catecholamines and pressor amines. Adding a catecholamine precursor like tyrosine raises the risk of a hypertensive reaction (the same concern that drives the tyramine-restricted diet on MAOIs).

    Do not combine tyrosine with MAO inhibitors without explicit medical supervision.

  • Other

    levothyroxinethyroid hormone medication

    Tyrosine is a precursor to thyroid hormone. Supplementing it could theoretically affect thyroid hormone levels, which matters in people with thyroid disease or on thyroid medication.

    If you have a thyroid condition or take thyroid medication, discuss tyrosine with your prescriber and monitor thyroid labs.

  • Reduces nutrient status

    levodopa (L-DOPA)

    Tyrosine and levodopa are large neutral amino acids that compete for the same intestinal and blood-brain-barrier transporters. Taking them together can reduce levodopa absorption and effect.

    Parkinson's patients on levodopa should separate it from tyrosine (and high-protein meals) and consult their neurologist.

Other critical caveats
  • Tyrosine's real, evidence-backed effect is narrow: it preserves cognitive performance under ACUTE stressors that deplete catecholamines — cold, sleep deprivation, multitasking, operational/military stress. It is NOT a daily focus or energy aid, and every positive trial required a stressor or high cognitive load to show an effect.
  • Tyrosine is not a mood booster or depression treatment. The Gelenberg 1990 RCT raised the catecholamine metabolite MHPG (proving the precursor reached its target) but produced no antidepressant effect, and the Deijen stress studies found cognitive benefit with explicitly no mood change.
  • N-acetyl-L-tyrosine (NALT) is marketed as 'better absorbed,' but it converts to tyrosine poorly and much of an oral dose is excreted in urine — it raises plasma tyrosine LESS reliably than plain L-tyrosine. The clinical trials all used free L-tyrosine.
  • Do not combine tyrosine with MAO inhibitors (hypertensive-reaction risk via the tyramine pathway). Use caution with thyroid medication (tyrosine is a thyroid-hormone precursor) and separate it from levodopa, which it competes with for absorption.
Frequently asked
  • Does L-tyrosine actually work for focus and energy?
    Only under stress. The trials are clear and consistent: tyrosine preserves cognitive performance when an acute stressor — cold, sleep deprivation, heavy multitasking, military training — is depleting your dopamine and norepinephrine faster than the brain can resynthesize them. In every study, the benefit showed up in the demanding condition and disappeared in the easy one. As a daily focus or energy pill for a rested, healthy person, it has no trial support.
  • Will L-tyrosine improve my mood or help with depression?
    No. A proper double-blind RCT (Gelenberg 1990) gave 65 people with major depression 100 mg/kg/day for 4 weeks and found no antidepressant effect — even though it confirmed the tyrosine was reaching the catecholamine pathway. The stress studies likewise found cognitive benefits with no change in mood. Tyrosine buffers the cognitive cost of acute stress; it does not lift mood and is not a depression treatment.
  • Is N-acetyl-L-tyrosine (NALT) better than regular L-tyrosine?
    No — despite the marketing. NALT dissolves more easily in water, which is why it's sold as 'more bioavailable,' but it converts to actual tyrosine poorly and a large share is excreted in urine before becoming usable. It raises plasma tyrosine less reliably than plain L-tyrosine. Every clinical trial used free L-tyrosine, so that's the form to buy.
  • How much L-tyrosine should I take?
    The acute-stress research used large single doses of 100–150 mg/kg — roughly 7–13 g for a 70 kg adult, far above the 500–2000 mg in typical supplements — taken about an hour before the stressful task. The multi-day military study used 2 g/day. There is no established benefit to small daily doses in the absence of a stressor.
  • Who should avoid L-tyrosine?
    Anyone on an MAO inhibitor (risk of a dangerous blood-pressure spike via the tyramine pathway), people with thyroid disease or on thyroid medication (tyrosine is a thyroid-hormone precursor — discuss with your prescriber), and people taking levodopa for Parkinson's (tyrosine competes with it for absorption and should be separated). When in doubt, check with your prescriber.

References

  1. 01Examine.com — Tyrosine
  2. 02Jongkees et al., 2015 — Tyrosine supplementation under stress or cognitive demands: a review (J Psychiatr Res)
  3. 03Neri et al., 1995 — Tyrosine and cognition during extended wakefulness (Aviat Space Environ Med)
  4. 04Mahoney et al., 2007 — Tyrosine mitigates working-memory decrements during cold (Physiol Behav)
  5. 05Gelenberg et al., 1990 — Tyrosine for depression: a double-blind trial, null result (J Affect Disord)

Last reviewed2026-05-24